Wasatch Advisors LP Sells 3,990 Shares of BriaCell Therapeutics Corp. (NASDAQ:BCTX)

Wasatch Advisors LP reduced its position in shares of BriaCell Therapeutics Corp. (NASDAQ:BCTX – Free Report) by 0.6% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 612,088 shares of the company’s stock after selling 3,990 shares during the period. Wasatch Advisors […]

Related Keywords

,Briacell Therapeutics Corp ,Wasatch Advisors Inc ,Briacell Therapeutics Company Profile ,Hightower Advisors ,Nasdaq ,Exchange Commission ,Topco Ltd ,Virtu Financial ,Wasatch Advisors ,Briacell Therapeutics ,Free Report ,Tower Advisors ,Cell Therapeutics Trading Down ,Cell Therapeutics ,Cell Therapeutics Corp ,Visit Holdingschannel ,Briacell Therapeutics Daily ,Nasdaq Bctx ,Bctx ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,